#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Huntington's disease Hepatitis D Craniopharyngioma Pancreatic carcinoma Cutaneous lupus erythematosus Nephropathy T-cell lymphoma Liver abscess Hepatoblastoma Plasma cell myeloma Pulmonary sarcoidosis Primitive neuroectodermal tumour Arterial disorder Non-renal cell carcinoma of kidney B-cell lymphoma recurrent More trials…

    Learn about Rare Diseases

    Undifferentiated sarcoma – Diagnostics Cystic fibrosis – Life with Disease Haemolytic uraemic syndrome – Basic Information Gastrointestinal stromal tumour – Treatment Immunodeficiency congenital Cystic fibrosis lung Marginal zone lymphoma refractory – Treatment Pelizaeus-Merzbacher disease – Diagnostics Myelodysplastic syndrome – Treatment Pulmonary fibrosis – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    AZD5335 Nelivaptan TEV-53408 Voclosporin YL201 Mk-2060 Topotecan Enx-101 Daratumumab Cpk850 Dermatophagoides Farinae Maralixibat Chloride L-Tryptophan Valaciclovir Oxaliplatin Lenograstim VERT-002 Chlorhexidine Dihydrochloride Crgd-Zw800-1 GSK5458514 More therapies…

    Learn about Your Condition

    Menopause Cytomegalovirus infection Retinopathy proliferative Asthmatic crisis Uterine leiomyosarcoma Eye pain Anaplastic thyroid cancer Petit mal epilepsy Genital infection female Lyme disease Hepatic cancer Bipolar disorder Tuberous sclerosis complex Cardiogenic shock Cervix carcinoma stage II More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study of Personalized Peptide Vaccine with PERVI-FUS, PERVI-NEO, and 11902A for Children and Young Adults with Metastatic Fusion-Driven Sarcomas

    Recruiting

    2 1 1
    Investigated Diseases:
    • Alveolar rhabdomyosarcoma
    • Synovial sarcoma
    • Ewing’s sarcoma
    Investigated Drugs:
    • 11902A
    • Pervi-Fus
    • Pervi-Neo
    Germany

  • Study on Capecitabine and Oxaliplatin for Patients with Advanced or Metastatic Gastrointestinal Cancer with CES1 Variant

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Gastrointestinal carcinoma
    Investigated Drugs:
    • Capecitabine
    • Oxaliplatin
    The Netherlands

  • Study on Sotagliflozin for Treating Low Blood Sugar After Weight Loss Surgery in Patients with Post-Bariatric Hypoglycemia

    Recruiting

    2 1 1
    Investigated Diseases:
    • Hypoglycaemia
    Investigated Drugs:
    • Sotagliflozin
    • Placebo
    Denmark

  • Study on Indocyanine Green in Axillary Lymph Nodes for Patients with Breast Cancer and Metastatic Lymph Nodes

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Breast cancer
    Investigated Drugs:
    • Indocyanine Green
    Italy

  • Study Comparing FDG-PET/CT and CT for Monitoring Treatment Response in Patients with Metastatic Breast Cancer Using Fludeoxyglucose (18F)

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Fludeoxyglucose (18F)
    Denmark Germany Italy

  • Study on the Safety and Effectiveness of Dazucorilant for Patients with Amyotrophic Lateral Sclerosis (ALS)

    Recruiting

    2 1 1
    Investigated Diseases:
    • Amyotrophic lateral sclerosis
    Investigated Drugs:
    • Dazucorilant
    Belgium France Germany Ireland The Netherlands Poland +1
Previous Page
1 … 611 612 613 614 615 … 1,654
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!